Johnson & Johnson (JNJ) Bets $700 Million on MacroGenics, Inc. (MGNX)'s Blood Cancer Drug
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD)
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely
FDA Approves AbbVie (ABBV)'s All-Oral Hepatitis C Drug Viekira Pak
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab
AstraZeneca PLC (AZN) Grabs Accelerated FDA Approval for Lynparza
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure
Big Pharmas Like Johnson & Johnson (JNJ), Boehringer Ingelheim Corporation. Eli Lilly (LLY), and Roche (RHHBY) are Shedding Jobs in Korea
Phylogica Ltd. Grabs $142 Million Deal With Genentech (RHHBY)
NewLink Genetics, Merck & Co. (MRK) Nabs $30 Million Government Contract For Ebola
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys
Merck & Co. (MRK) Snaps Up Swiss Biotech In $375 Buyout Deal
AstraZeneca PLC (AZN) To Slash 250 Jobs As Another Plant Faces Shutdown
Eli Lilly (LLY), Adocia Ink $570 Million Pact To Develop Fast-Acting Insulin
GlaxoSmithKline (GSK) Reassure Investors That Dividend Is Safe As Analysts Question Payout
Vernalis PLC (VNLPY.PK) Stumbles As Novartis AG (NVS) Abandons Work On AUY922
See All News >
//-->